New Evidence Supporting Cyclosporine Efficacy in Epidermal Necrolysis.

Related Articles

New Evidence Supporting Cyclosporine Efficacy in Epidermal Necrolysis.

J Invest Dermatol. 2017 Oct;137(10):2047-2049

Authors: Roujeau JC, Mockenhaupt M, Guillaume JC, Revuz J

Abstract
Sixty years after its original description by Sir Alan Lyell, epidermal necrolysis (from Stevens-Johnson syndrome to toxic epidermal necrolysis) seems finally amenable to a specific treatment in addition to essential symptomatic measures in specialized settings. A recently published systematic review and an article by Gonzales-Herrada et al. strongly suggest that cyclosporine is effective in reducing the risk of death.

PMID: 28941473 [PubMed - indexed for MEDLINE]

from #ORL via xlomafota13 on Inoreader http://ift.tt/2ykHEmd
via IFTTT